In a review of 182 cancer studies, authors failed to report outcome data by sex in 90% of cases, even though men develop ...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company, announced today that its BTK inhibitor orelabrutinib received approval from the China National Medical Products ...

Limited’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

A new study suggests that people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) may live longer ...

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and ...

Statin therapy potentially reduces cancer mortality risk by 60%, a new study indicates. LONDON, April 24: ...

Studies have shown that using statin drugs used to treat hyperlipidemia as a combination therapy can reduce the risk of ...

Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering statin medications at the start of their cancer treatment had a 61% lower risk ...

Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering ...

Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering statin medications at the ...

Patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who were taking cholesterol-lowering statin ...

Ascentage Pharma (AAPG) announced that two of its proprietary novel drugs have been included in the 2025 Chinese Society of Clinical Oncology, ...